Skip to main content

Dbv Technologies ADR(DBVT-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

DBV Technologies to Present at the Oppenheimer’s 32nd Annual Healthcare Conference

Globe Newswire - Mon Mar 14, 2022

Montrouge, France, March 14, 2022
DBV Technologies to Present at the Oppenheimer’s 32nd Annual Healthcare Conference

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Dr. Pharis Mohideen, Chief Medical Officer, will present at the Oppenheimer’s 32nd Annual Healthcare Conference on Thursday, March 17th at 10:00 a.m. ET.

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe